研究者業績

千原 猛

チハラ タケシ  (Chihara Takeshi)

基本情報

所属
藤田医科大学 医療科学部 臨床検査学科 准教授
学位
博士(医学)(藤田保健衛生大学)

J-GLOBAL ID
200901075510286403
researchmap会員ID
1000102768

論文

 29
  • Yoshihiro Uekuzu, Takashi Higashiguhi, Akihiko Futamura, Akihiro Ito, Naoharu Mori, Miyo Murai, Hiroshi Ohara, Hiroko Awa, Takeshi Chihara
    BIOLOGICAL & PHARMACEUTICAL BULLETIN 40(3) 278-283 2017年3月  査読有り
    There have been few detailed reports on respiratory depression due to overdoses of opioids in terminal cancer patients. We investigated the situation of treatment with opioid antagonists for respiratory depression that occurred after administration of opioid at optimal doses in terminal cancer patients, to clarify pathological changes as well as causative factors. In 2443 terminal cancer patients receiving opioids, 7 patients (0.3%) received opioid antagonists: 6, morphine (hydrochloride, 5; sulfate, 1); 1, oxycodone. The median dosage of opioids was 13.3 mg/d, as converted to morphine injection. Respiratory depression occurred on this daily dose in 4 patients and after changed dose and route in 3 patients. Opioids were given through the vein in 6 patients and by the enteral route in 1 patient. Concomitant drugs included nonsteroidal anti-inflammatory drugs in 3 patients and zoledronic acid in 2 patients. In morphine-receiving patients, renal functions were significantly worsened at the time of administration of an opioid antagonist than the day before the start of opioid administration. These findings indicate that the proper use of opioids was safe and acceptable in almost all terminal cancer patients. In rare cases, however, a risk toward respiratory depression onset is indicated because morphine and morphine-6-glucuronide become relatively excessive owing to systemic debility due to disease progression, especially respiratory and renal dysfunctions. At the onset of respiratory depression, appropriate administration of an opioid antagonist mitigated the symptoms. Thereafter, opioid switching or continuous administration at reduced dosages of the same opioids prevented the occurrence of serious adverse events.
  • Hiroko Awa, Akihiko Futamura, Takashi Higashiguchi, Akihiro Ito, Naoharu Mori, Miyo Murai, Hiroshi Ohara, Takeshi Chihara, Takaaki Kaneko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN 40(3) 266-271 2017年3月  査読有り
    A functional dietary supplement (FDS) containing Coenzyme Q10, branched-chain amino acids and L-carnitine was administered to tumor-bearing mice, investigating its effects on tumor and muscle tissues. Experiment (A): B16 melanoma cells were implanted subcutaneously into the right side of the abdomen of 8- to 9 -week-old C57BL/6J mice. The mice were divided into two groups: a FDS group that received oral administration of FDS (n=10), and a control group that received oral administration of glucose (n=10). The moribund condition was used as the endpoint, and median survival time was determined. Experiment (B): On day 21 after tumor implantation, tumors, soleus muscle, gastrocnemius muscle, and suprahyoid muscles were collected. Tumor and muscle weight and other aspects were evaluated in each group: FDS group (n=15) and control group (n=15). The median survival time was comparable (21 d in the FDS group vs. 18 d in the control group, p=0.30). However, cumulative food intake was significantly higher in the FDS group than the control group (p=0.011). Metastasis of melanoma to the lung was observed in the control group but not in the FDS group (p=0.043). The weight of the suprahyoid muscles was significantly higher in the FDS group than in the control group (p=0.0045). The weight of the tumor was significantly lower in the FDS group than in the control group (p=0.013). The results possibly suggest oral administration of FDS in tumor-bearing mice enhances the maintenance of suprahyoid muscles, resulting in an extended feeding period and suppression of tumor growth and metastasis.
  • Abbas Orand, Hiroyuki Miyasaka, Kotaro Takeda, Genichi Tanino, Takeshi Chihara, Hidehiko Beppu, Shigeru Sonoda
    BIOCYBERNETICS AND BIOMEDICAL ENGINEERING 37(1) 114-123 2017年  査読有り
    The consistency of torque measurements during repetitive moving arm movements and also during passive wrist movements at two angular velocities of slow (similar to 6 degrees/s) and moderate (similar to 120 degrees/s) was investigated. The designed and developed device was applied to 3 cases, to a spring, to 8 able-bodied subjects and to 2 hemiplegic patients. While the mean of the intra-class correlation coefficient of subjects were 0.65 and 0.75 for slow and moderate angular velocities, those of the hemiplegic patients and the spring respectively ranged between excellent values of 0.93-1 and 0.91-1. The Pearson's product-moment correlation coefficients of the 3 cases for the 2 slow and moderate angular velocities ranged between 0.80 and 1. We could verify that the device can be used in our future researches and it can (1) reliably rotate a moving arm horizontally with angular velocities between 3 and 350 degrees/s constantly in a range of motion between -60 and 60 degrees and (2) simultaneously capture the data of angular displacement, torque, and two electromyogram activities. For the standardization of our future studies with the device, we could verify the stability of the last two repeated passive wrist movements in case of patients. The results of the study with the able-bodied subjects are also important as a reference for our studies with the hemiplegic. (C) 2017 The Authors. Published by Elsevier B.V. on behalf of Nalecz Institute of Biocybemetics and Biomedical Engineering of the Polish Academy of Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
  • Kenmei Mizutani, Shigeru Sonoda, Hideaki Wakita, Hideto Okazaki, Yoshimitsu Katoh, Takeshi Chihara, Kan Shimpo
    NEUROREPORT 27(9) 659-664 2016年6月  査読有り
    Although it has been suggested that the combination of exercise and bryostatin-1 administration may induce greater functional recovery than exercise alone, the detailed molecular mechanisms are not well known. Here, we examined the relationship between this combination treatment and monoamine dynamics in the cerebral cortex peri-infarction area to promote our understanding of these molecular mechanisms. Experimental cerebral cortex infarctions were produced by photothrombosis in rats. Voluntary exercise was initiated 2 days after surgery. Motor performance was then measured using the rotarod test. Monoamine concentrations in the perilesional cortex were analyzed by high-performance liquid chromatography. In behavioral evaluations, performance in the rotarod test was significantly increased by exercise. Moreover, performance in the rotarod test after the combination of exercise and bryostatin-1 administration was significantly greater than that after exercise alone. In the analysis of monoamines, serotonin (5-HT) concentrations were significantly higher in the groups treated with exercise and bryostatin-1. In addition, 5-HT turnover was significantly lower in the groups treated with exercise and bryostatin-1. Furthermore, the mean latency in the rotarod test showed a significant positive correlation with 5-HT levels. In immunohistochemical analysis, 5-HT immunoreactivity in the dorsal raphe nucleus was shown to be higher in the groups treated with exercise. In the present study, we detected changes in the levels of monoamines associated with the combined treatment of exercise and bryostatin-1 administration in the perilesional cortex. It has been suggested that this combination of therapies may affect 5-HT turnover and serve to increase local 5-HT concentrations in the perilesional area. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.
  • 新保 寛, 千原 猛, 金児孝晃, 別府秀彦
    薬理と臨床 23(3) 97-104 2016年  
  • Kan Shimpo, Takeshi Chihara, Hidehiko Beppu, Takaaki Kaneko, Masanori Shinzato, Kazumasa Wakamatsu, Takashi Higashiguchi, Shigeru Sonoda
    薬理と臨床 26(2) 45-54 2016年  
  • Takeshi Chihara, Kan Shimpo, Takaaki Kaneko, Hidehiko Beppu, Takashi Higashiguchi, Shigeru Sonoda
    International Journal of Analytical Bio-Science 4(1) 13-19 2016年  査読有り
  • Takaaki Kaneko, Takeshi Chihara, Kan Shimpo, Hidehiko Beppu, Takashi Higashiguchi, Shigeru Sonoda
    Asian Pacific Journal of Cancer Prevention 16(9) 3881-3885 2015年  査読有り
    Obesity markedly increases the risk of colorectal cancer. Recently, the preventive effects of edible mushrooms on triglyceride elevation and visceral fat accumulation have been reported. Here, the effects of Pleurotus eryngii (Eringi) and Hypsizygus marmoreus (Bunashimeji) on azoxymethane (AOM)-induced aberrant crypt foci (ACF precancerous lesions) in the colorectums of mice fed a high-fat diet were examined. Eringi (ER) and Bunashimeji (BU) mushroom powder samples were used. Six-week-old male C57BL/6J mice received an intraperitoneal injection of AOM (10 mg/kg) once a week for two weeks, and were sacrificed and dissected at 6 weeks after the start of the experiment. After the initiation of the experiment, they received a normal diet (ND), high-fat diet (HFD), HFD + ER (1 or 5% of diet), or HFD + BU (1 or 5% of diet). As a result, body and fat weights were significantly lower in the 5% ER and BU groups than in the HFD group. Liver triglyceride levels were also significantly lower in the 5% ER and BU groups. Total liver cholesterol levels were significantly lower in the 5% ER group. The numbers of ACF (especially large ACF) showed strong inhibitory effects in both ER and BU groups. Measurement of the cell proliferation marker Ki-67 labeling index in the colonic mucosa demonstrated more significant suppression in both ER and BU groups than in the HFD group. These results suggest that the simultaneous intake of ER and BU may inhibit colorectal tumorigenesis in HFD-fed mice.
  • Takeshi Chihara, Kan Shimpo, Hidehiko Beppu, Naoki Yamamoto, Takaaki Kaneko, Kazumasa Wakamatsu, Shigeru Sonoda
    Asian Pacific Journal of Cancer Prevention 16(9) 3887-3891 2015年  査読有り
    Aloe-emodin (1, 8-dihydroxy-3-hydroxyl-methylanthraquinone AE) and emodin (1,3,8-trihydroxy-6-methylanthraquinone EM) are anthraquinone derivatives that have been detected in some medical plants and share similar anthraquinone structures. AE and EM have been shown to exhibit anticancer activities in various cancer cell lines however, the inhibitory effects of these derivatives on the growth of cancer cells were previously reported to be different. Gastric cancer is the second most common cause of cancer cell death worldwide. In the present study, we examined the inhibitory effects of 0.05 mM AE and 0.05 mM EM on the proliferation of the MKN45 human gastric cancer cell line. The proliferation of MKN45 cells was significantly inhibited in AE- and EM-treated groups 24 h and 48 h after treatment. Furthermore, the inhibitory effects of EM were stronger than those of AE. The cell cycle of MKN45 cells were arrested in G0/G1 phase or G0/G1 and G2/M phases by AE and EM, respectively. However, an analysis of intracellular polyamine levels and DNA fragmentation revealed that the mechanisms underlying cell death following cell arrest induced by AE and EM differed.
  • Takesi Chihara, Kan Shimpo, Hidehiko Beppu, Takaaki Kaneko, Takashi Higashiguchi, Shigeru Sonoda, Miyuki Tanaka, Muneo Yamada, Fumiaki Abe
    Pharmaceutica Analytica Acta 6 1000340 2015年  査読有り
  • Takeshi Chihara, Kan Shimpo, Takaaki Kaneko, Hidehiko Beppu, Takashi Higashiguchi, Shigeru Sonoda, Miyuki Tanaka, Muneo Yamada, Fumiaki Abe
    Asian Pacific Journal of Cancer Prevention 16(2) 683-687 2015年  査読有り
    Aloe vera gel exhibits protective effects against insulin resistance as well as lipid-lowering and anti-diabetic effects. The anti-diabetic compounds in this gel were identified as Aloe-sterols. Aloe vera gel extract (AVGE) containing Aloe-sterols has recently been produced using a new procedure. We previously reported that AVGE reduced large-sized intestinal polyps in Apc-deficient Min mice fed a high fat diet (HFD), suggesting that Aloe vera gel may protect against colorectal cancer. In the present study, we examined the effects of Aloe vera gel powder (AVGP) and AVGE on azoxymethane-induced colorectal preneoplastic aberrant crypt foci (ACF) in mice fed a HFD. Male C57BL/6J mice were given a normal diet (ND), HFD, HFD containing 0.5% carboxymethyl cellulose solution, which was used as a solvent for AVGE (HFDC), HFD containing 3% or 1% AVGP, and HFDC containing 0.0125% (H-) or 0.00375% (L-) AVGE. The number of ACF was significantly lower in mice given 3% AVGP and H-AVGE than in those given HFD or HFDC alone. Moreover, 3% AVGP, H-AVGE and L-AVGE significantly decreased the mean Ki-67 labeling index, assessed as a measure of cell proliferation in the colonic mucosa. In addition, hepatic phase II enzyme glutathione S-transferase mRNA levels were higher in the H-AVGE group than in the HFDC group. These results suggest that both AVGP and AVGE may have chemopreventive effects on colorectal carcinogenesis under the HFD condition. Furthermore, the concentration of Aloe-sterols was similar between 3% AVGP and H-AVGE, suggesting that Aloe-sterols were the main active ingredients in this experiment.
  • Kan Shimpo, Takeshi Chihara, Takaaki Kaneko, Hidehiko Beppu, Kazumasa Wakamatsu, Masanori Shinzato, Jun Yukitake, Shigeru Sonoda
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 15(14) 5587-5592 2014年  査読有り
    Aloe-emodin (AE), a natural anthraquinone compound, has been reported to exhibit anticancer activity in various cancer cell lines and anti-inflammatory effects in murine macrophages. In the present study, we investigated the cancer chemopreventive effects of AE in an Apc-deficient Min mouse model. In the first experiment, male Min mice were fed a basal diet or diets containing 5 ppm AE and 10 ppm AE for 12 weeks. The dietary administration of 5 ppm AE significantly reduced the number of colorectal tumors. In a second experiment, we investigated the effects of AE on colitis-related colon carcinogenesis in Min mouse treated with dextran sodium sulfate (DSS). Female Min mice were administered 1% DSS in their drinking water for 7 days. AE was given to mice in their diet at a dose of 5 or 50 ppm for 5 weeks. Feeding with AE significantly reduced the number of colorectal tumors. When proliferation of cells in normal-appearing colonic mucosa was assessed by monoclonal anti-rat Ki-67 antibody (MIB-5) immunohistochemistry in experiments 1 and 2, the AE treatment significantly decreased the mean MIB-5-labeling index. These results suggest that the dietary administration of low-dose AE may have chemopreventive effects against development of colorectal tumors in Min mice, possibly in part by reducing cell proliferation in colorectal mucosa.
  • Takeshi Chihara, Kan Shimpo, Takaaki Kaneko, Akiko Tomatsu, Hidehiko Beppu
    Journal of Analytical Bio-Science 36(2) 186-192 2013年  査読有り
  • Akihiko Futamura, Takashi Higashiguchi, Akihiro Ito, Yoshiyuki Kodama, Takeshi Chihara, Takaaki Kaneko, Akiko Tomatsu, Kan Shimpo
    WOUNDS 25(7) 186-192 2013年  査読有り
  • Takeshi Chihara, Kan Shimpo, Hidehiko Beppu, Akiko Tomatsu, Takaaki Kaneko, Miyuki Tanaka, Muneo Yamada, Fumiaki Abe, Shigeru Sonoda
    Asian Pacific Journal of Cancer Prevention 14(7) 4435-4440 2013年  査読有り
    Aloe vera gel supercritical CO2 extract (AVGE) has been shown to contain five phytosterols, reduce visceral fat accumulation, and influence the metabolism of glucose and lipids in animal model experiments. Recent epidemiologic studies have shown that obesity is an established risk factor for several cancers including colorectal cancer. Therefore, we examined the effects of AVGE on intestinal polyp formation in Apc-deficient Min mice fed a high-fat diet. Male Min mice were divided into normal diet (ND), high fat diet (HFD), low dose AVGE (HFD+LAVGE) and high dose AVGE (HFD+HAVGE) groups. The ND group received AIN-93G diet and the latter 3 groups were given modified high-fat AIN-93G diet (HFD) for 7 weeks. AVGE was suspended in 0.5% carboxymethyl cellulose (CMC) and administered orally to mice in HFD+LAVGE and HFD+HAVGE groups every day (except on Sunday) for 7 weeks at a dose of 3.75 and 12.5 mg/kg body weight, respectively. ND and HFD groups received 0.5% CMC alone. Between weeks 4 and 7, body weights in the HFD and HFD+LAVGE groups were reduced more than those in the ND group. However, body weights were not reduced in the HFD+HAVGE group. Mice were sacrificed at the end of the experiment and their intestines were scored for polyps. No significant differences were observed in either the incidence and multiplicity of intestinal polyps (≤0.5 mm in a diameter) among the three groups fed HFD. However, when intestinal polyps were categorized by their size into 0.5-1.4, 1.5-2.4, or ≥2.5 mm, the incidence and multiplicity of large polyps (≥2.5 mm) in the intestine in the HFD+HAVGE group were significantly lower than those in the HFD group. We measured plasma lipid (triglycerides and total cholesterol) and adipocytokine [interleukin-6 and high molecular weight (HMW) adiponectin] levels as possible indicators of mechanisms of inhibition. The results showed that HMW adiponectin levels in the HFD group were significantly lower than those in the ND group. However, the levels in the HFD+HAVGE group were significantly higher than those in the HFD group. These results indicate that HAVGE reduced large-sized intestinal polyps and ameliorated reduction in plasma HMW adiponectin levels in Min mice fed HFD.
  • Takaaki Kaneko, Kan Shimpo, Takeshi Chihara, Hidehiko Beppu, Akiko Tomatsu, Masanori Shinzato, Takamasa Yanagida, Tsutomu Ieike, Shigeru Sonoda, Akihiko Futamura, Akihiro Ito, Takashi Higashiguchi
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 13(5) 1983-1988 2012年  査読有り
    High temperature- and pressure-treated garlic (HTPG) has been shown to have enhanced antioxidative activity and polyphenol contents. Previously, we reported that HTPG inhibited 1,2-dimethylhydrazine-induced mucin depleted foci (premalignant lesions) and O-6-methylguanine DNA adduct formation in the rat colorectum. In the present study, we investigated the modifying effects of HTPG on N-ethyl-N'-nitro-N-nitrosoguanidine (ENNG)-induced pyloric stomach and small intestinal carcinogenesis in mice. Male C57BL/6 mice were given ENNG (100 mg/l) in drinking water for the first 4 weeks, then a basal diet or diet containing 2% or 5% HTPG for 30 weeks. The incidence and multiplicity of pyloric stomach and small intestinal (duodenal and jejunal) tumors in the 2% HTPG group (but not in the 5% HTPG group) were significantly lower than those in the control group. Cell proliferation of normal-appearing duodenal mucosa was assessed by MIB-5 immunohistochemistry and shown to be significantly lower with 2% HTPG (but again not 5% HTPG) than in controls. These results in dicate that HTPG, at 2% in the diet, inhibited ENNG-induced pyloric stomach and small intestinal (especially duodenal) tumorigenesis in mice, associated with suppression of cell proliferation.
  • Kunihiro Hosono, Hiroki Endo, Hirokazu Takahashi, Michiko Sugiyama, Takashi Uchiyama, Kaori Suzuki, Yuichi Nozaki, Kyoko Yoneda, Koji Fujita, Masato Yoneda, Masahiko Inamori, Akiko Tomatsu, Takeshi Chihara, Kan Shimpo, Hitoshi Nakagama, Atsushi Nakajima
    MOLECULAR CARCINOGENESIS 49(7) 662-671 2010年7月  
    Metformin is widely used for the treatment of diabetes mellitus. Adenosine monophosphate-activated protein kinase (AMPK) is known to be activated by metformin and to inhibit the mammalian target of rapamycin (mTOR) pathway. The mTOR pathway plays an important role in the protein translational machinery and cell proliferation. We examined the effect of metformin on the suppression of colorectal carcinogenesis in chemical carcinogen-induced models. Seven-wk-old BALB/c mice were intraperitoneally (i.p.) injected with azoxymethane (AOM, 10 mg/kg) and then treated with or without metformin (250 mg/kg/d) for 6 wk (for the investigation of aberrant crypt foci [ACF] formation) or 32 wk (for polyp formation). We next investigated colonic epithelial proliferation using bromodeoxyuridine (BrdU) and the proliferating cell nuclear antigen (PCNA) labeling indices. Furthermore, to examine the indirect effect of metformin, the insulin resistance status and the serum lipid levels were assessed. Treatment with metformin significantly reduced ACF formation. The effect of metformin on colon polyp inhibition was relatively modest. No significant difference in body weight or glucose concentration was observed. The BrdU and PCNA indices decreased in mice treated with metformin. A Western blot analysis revealed that the phosphorylated mTOR, S6 kinase, and S6 protein levels in the colonic mucosa decreased significantly in mice treated with metformin. In conclusion, metformin suppresses colonic epithelial proliferation via the inhibition of the mTOR pathway through the activation of AMPK. As metformin is already used daily as an antidiabetic drug, it might be a safe and promising candidate for the chemoprevention of colorectal cancer. (c) 2010 Wiley-Liss, Inc.
  • Takeshi Chihara, Kan Shimpo, Takaaki Kaneko, Hidehiko Beppu, Kenmei Mizutani, Takashi Higashiguchi, Shigeru Sonoda
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 11(5) 1301-1304 2010年  
    The scavenging capacity of reactive oxygen species, such as hydroxyl radicals, is reported not to decrease in boiled garlic (an odorless garlic preparation). We therefore examined the modifying effect of boiled garlic powder (BGP) on 1,2-dimethylhydrazine-induced mucin-depleted foci (MDF) and aberrant crypt foci (ACF), preneoplastic lesions, in the rat colorectum. Male F344 rats (5 weeks old) were fed a basal diet, or experimental diets containing 5% or 1% BGP for 5 weeks. One week later, all rats were injected s.c. with DMH (40 mg/kg, once weekly for 2 weeks). At 10 weeks of age, all the rats were sacrificed, and the colorectum was evaluated for MDF and ACF. In rats given DMH and the 5% or 1% BGP diets (Groups 2 and 3), the numbers of MDF decreased significantly in a dose-dependent manner, compared with the DMH and basal diet value (Group 1) (p < 0.01). The numbers of ACF in Group 2, but not Group 3, showed a non-significant tendency to decrease. Next, the effects of BGP on the formation of DMH-induced O-6-methylguanine (O-6-MeG) DNA adducts in rats were studied. Male F344 rats (5 weeks old) were fed the basal diet, or 10% BGP diet for 5 weeks. All rats were injected i.p. once with 40 mg/kg DMH at the end of week 5. The animals were sacrificed 6 hours after DMH injection to analyze the O-6-MeG DNA adducts in the colorectal mucosa. Dietary administration of BGP significantly inhibited the O-6-MeG DNA adduct levels in the colorectal mucosa, compared with the controls (p < 0.01). These results suggested that BGP may exert chemopreventive effects against colon carcinogenesis at least in the initiation stage.
  • H.Beppu, Y.Matsumoto, T.Fujino, Y.Itani, T.Sumitho, T.Higashiguchi, T.Chihara, I.Tamai, S.Sonoda, K.Shimpo
    Journal of Analytical Bio-Science 33(5) 441-450 2010年  
  • Takeshi Chihara, Kan Shimpo, Takaaki Kaneko, Hidehiko Beppu, Akiko Tomatsu, Shigeru Sonoda
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 10(5) 827-831 2009年  
    High temperature- and pressure-treated garlic (HTPG) has been reported to have enhanced antioxidative and cytotoxic activities. However, there have been no reports on chemopreventive effects using animal cancer models. This study first examined the modifying effects of HTPG on 1,2-dimethylhydrazine (DMH)-induced mucin-depleted foci (MDF) and aberrant crypt foci (ACF), preneoplastic lesions in the rat colorectum. Male F344 rats (5 weeks old) were fed basal diet, or experimental diets containing 1% or 3% HTPG for 5 weeks. One week later, all rats were injected s.c. with DMH (40 mg/kg, once weekly for 2 weeks). At 10 weeks of age, all the rats were sacrificed, and the colorectum was evaluated for MDF and ACF. In rats given DMH and 3% HTPG, the numbers of MDF were decreased significantly as compared with those of rats given DMH alone (p<0.01), and the numbers of ACF showed a tendency to decrease, although not significantly. Next, the effects of HTPG on the formation of DMH-induced O-6-methylguanine (O-6-MeG) DNA adducts in rats were studied. Male F344 rats (5 weeks old) were fed the basal diet or 10% HTPG diet for 5 weeks. All rats were injected i.p. once with 40 mg/kg DMH at the end of week 5. The animals were sacrificed 6 hours after DMH injection to analyze the O-6-MeG DNA adducts in the colorectal mucosa and liver. Dietary administration of HTPG significantly reduced the adduct levels in the colorectal mucosa and liver, compared with the controls (both p<0.01). The activities of some detoxification enzymes in the liver of DMH-treated rats were also measured. HTPG significantly reduced the activity of cytochrome P450 (CYP) 2E1, known to be responsible for activation of DMH in rat liver (p<0.05). In contrast, HTPG significantly enhanced the activities of phase 2 enzymes, quinone reductase (QR) and glutathione S-transferase (GST), in rat liver (both p<0.05). These results suggested that HTPG might have chemopreventive effects against colon carcinogenesis, at least in the initiation stage.
  • 千原 猛, 新保 寛, 井田千賀子, 金児孝晃, 濱島 剛, 伊藤祥輔, 永津俊治, 葛谷博磁
    藤田学園医学会誌 25(1) 57-60 2001年  査読有り
  • 千原 猛, 新保 寛, 別府秀彦, 井田千賀子, 金児孝晃, 新里雅範, 川井 薫, 廣野 巌, 社本幹博, 永津俊治, 葛谷博磁
    藤田学園医学会誌 24(2) 223-226 2000年  査読有り
  • 新保 寛, 千原 猛, 別府秀彦, 金児孝晃, 井田千賀子, 葛谷博磁, 永津俊治
    藤田学園医学会誌 12(1) 123-127 1999年  査読有り
  • 川井 薫, 別府秀彦, 新保 寛, 千原 猛, 山本直樹, 永津俊治, 上田 宏, 葛谷博磁, 山田保雄
    藤田学園医学会誌 23(1) 109-115 1999年  査読有り
  • 千原 猛, 新保 寛, 別府秀彦, 金児孝晃, 井田千賀子, 葛谷博磁, 永津俊治
    藤田学園医学会誌 22(2) 153-157 1998年  査読有り
  • 新保 寛, 井田千賀子, 別府秀彦, 千原 猛, 川井 薫, 葛谷博磁, 永津俊治
    藤田学園医学会誌 22(1) 157-163 1998年  査読有り
  • 川井 薫, 千原 猛, 別府秀彦, 田祐光, 伊藤 圓, 永津俊治
    医学と生物学 132(1) 43-48 1996年  査読有り
  • 新保 寛, 千原 猛, 日比谷 信, 伊藤祥輔, 永津俊治
    日本臨牀 54(6) 49-54 1996年  招待有り
  • 川井 薫, 津田洋幸, 千原 猛, 別府秀彦, 新保 寛, 永津俊治, 廣野 巌, 藤田啓介
    医学と生物学 125(5) 189-194 1992年11月  査読有り

MISC

 59

講演・口頭発表等

 38

共同研究・競争的資金等の研究課題

 8

教育内容・方法の工夫(授業評価等を含む)

 10
  • 件名
    生化学講義の分担
    開始年月日
    2012/06/05
    終了年月日
    2012/06/26
    概要
    藤田保健衛生大学医療科学部医療経営情報学科1年生の「生化学」の講義を分担
  • 件名
    生理学実習の指導分担
    開始年月日
    2012/09/26
    終了年月日
    2012/11/02
    概要
    藤田保健衛生大学医療科学部臨床検査学科2年生の「生理学実習」の指導分担
  • 件名
    生化学講義の分担
    開始年月日
    2013/06/12
    終了年月日
    2013/06/26
    概要
    藤田保健衛生大学医療科学部医療経営情報学科1年生の「生化学」の講義を分担
  • 件名
    生理学実習の指導分担
    開始年月日
    2013/09/25
    終了年月日
    2013/11/01
    概要
    藤田保健衛生大学医療科学部臨床検査学科2年生の「生理学実習」の指導分担
  • 件名
    形態機能学Ⅲ講義の分担
    開始年月日
    2013/11/25
    終了年月日
    2013/12/09
    概要
    三重県立看護大学看護学部看護学科1年生の「形態機能学Ⅲ」の講義を分担
  • 件名
    生化学講義の分担
    開始年月日
    2016/06/01
    終了年月日
    2016/07/06
    概要
    藤田保健衛生大学医療科学部医療経営情報学科1年生の「生化学」の講義の分担
  • 件名
    生化学講義の分担
    開始年月日
    2014/04/30
    終了年月日
    2014/05/28
    概要
    藤田保健衛生大学医療科学部医療経営情報学科1年生の「生化学」の講義の分担
  • 件名
    生理学実習の指導分担
    開始年月日
    2014/09/24
    終了年月日
    2014/10/30
    概要
    藤田保健衛生大学医療科学部臨床検査学科2年生に「生理学実習」の指導分担
  • 件名
    生化学講義の分担
    開始年月日
    2015/04/15
    終了年月日
    2015/06/24
    概要
    藤田保健衛生大学医療科学部医療経営情報学科1年生の「生化学」の講義の分担
  • 件名
    生理学実習の分担
    開始年月日
    2015/09/24
    終了年月日
    2015/10/30
    概要
    藤田保健衛生大学医療科学部臨床検査学科2年生の「生理学実習」の指導分担

作成した教科書、教材、参考書

 2
  • 件名
    医学領域における臨床検査学入門(藤田保健衛生大学「臨床検査学入門」編集委員会 編著、KTC中央出版)第2版
    終了年月日
    2009/07/24
    概要
    臨床検査技師国家試験対策参考書、臨床検査総論の項を分担執筆
  • 件名
    医学領域における臨床検査学入門(藤田保健衛生大学「臨床検査学入門」編集委員会 編著、KTC中央出版)第3版
    終了年月日
    2013/07/03
    概要
    臨床検査技師国家試験対策参考書、臨床検査総論の項を分担執筆

その他教育活動上特記すべき事項

 2
  • 件名
    平成24年度愛知県高等学校文化連盟自然科学部講習会講師
    終了年月日
    2012/11/10
    概要
    愛知県高等学校自然科学部の教師および学生に、「動物の取り扱い」についての講義および動物実験手技の実習指導
  • 件名
    平成25年度愛知県高等学校文化連盟自然科学部講習会講師
    終了年月日
    2013/10/26
    概要
    愛知県高等学校自然科学部の教師および学生に、「動物の取り扱い」についての講義および動物実験手技の実習指導